Susco Posted September 9, 2020 Share Posted September 9, 2020 https://finance.yahoo.com/news/astrazeneca-puts-covid-19-vaccine-215143688.html Link to comment Share on other sites More sharing options...
Popular Post dabhand Posted September 9, 2020 Popular Post Share Posted September 9, 2020 Given that there are 50,000 taking part in these tests it is not really surprising that some will fall ill during the course of the trial, more than likely for unconnected reasons. In fact I would be more suspicious of any trials of that size where no illnesses were being reported. 3 Link to comment Share on other sites More sharing options...
geriatrickid Posted September 9, 2020 Share Posted September 9, 2020 (edited) Normal practice to suspend new dosing. The SOP is to verify if the batch was compromised, and if the patient had an existing condition that was missed at screening. In addition, to the review of the adverse reaction response. I hope the courageous volunteer recovers. I wouldn't rule out sabotage either. There are foreign entities who do not wish to see a "western" vaccine succeed particularly one that will be available to the world at low cost and with no strings attached. Edited September 9, 2020 by geriatrickid 2 Link to comment Share on other sites More sharing options...
mommysboy Posted September 9, 2020 Share Posted September 9, 2020 It's not unusual for illnesses to be wrongly ascribed to vaccines, but it is right to halt a trial for safety reasons. Link to comment Share on other sites More sharing options...
PPMMUU Posted September 10, 2020 Share Posted September 10, 2020 Said complication is a transverse myelitis which have an incidence of 2-4/1,000,000 If the rate of people developing transverse myelitis is 100-fold higher in vaccine group, there are chances that this particular vaccine is not gonna be approved. finger crossed that this in an unrelated event. Link to comment Share on other sites More sharing options...
Bkk Brian Posted September 12, 2020 Share Posted September 12, 2020 Good news, trials back on. Oxford University and AstraZeneca are resuming their mass coronavirus vaccine trial in the UK after a review concluded following a week long pause over safety concerns. https://www.lbc.co.uk/news/oxford-covid-19-vaccine-trials-resume-after-patient-fell-ill/ Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now